Seven Mandatory Items of the Third-Party Manufacturing Contract
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Article 11.8 of the main regulation requires that, in third-party manufacturing arrangements (fabricación por terceros), the manufacturing contract or the relevant extract concerning the parties to the contract be submitted, in the form of the original or a certified copy of a legalised or apostilled document, and that it contain at least seven items: signature by both parties (11.8.1); the commitment to comply with BPM (11.8.2); production and analytical conditions or other relevant technical management (11.8.3); handling of raw materials, finished products and non-conforming product (11.8.4); permission for the contracting party to enter the contracted party’s premises for audits (11.8.5); the list of products or analytical services covered by the contract (11.8.6); and the complete information of both parties together with the contract’s validity period and product type (11.8.7).
- An extract of the contract is acceptable, provided all seven mandatory items are contained in it.
- Signature form is differentiated: Costa Rican entities must sign with the legal representative’s digital signature.
- Foreign signatures follow the legalisation or apostille route of Article 10.17.
- The audit right of the contracting party is a mandatory clause, not an optional extra.
- The contract’s validity period links to renewal under Article 16.3: an expired contract must be replaced with a current one at renewal.
2. Legal basis
The seven-item list sits in Article 11.8 and its sub-items, and it is linked to renewal and change filings by the provisions listed below.
| Level | Instrument | Provision | Key point |
| Technical regulation | RTCR 505:2022 | Article 11.8 | Third-party manufacturing requires the contract or a relevant extract, as the original or a certified copy of a legalised or apostilled document |
| Technical regulation | RTCR 505:2022 | 11.8.1 | Signed by the holder and the manufacturer jointly or separately; Costa Rican entities must use the legal representative’s digital signature |
| Technical regulation | RTCR 505:2022 | 11.8.2 | Commitment to comply with BPM |
| Technical regulation | RTCR 505:2022 | 11.8.3 | Conditions for production, analysis (where applicable) or other relevant technical management |
| Technical regulation | RTCR 505:2022 | 11.8.4 | Management of raw materials, packaging materials, bulk product and finished product, and the handling of rejected items |
| Technical regulation | RTCR 505:2022 | 11.8.5 | The contracting party (contratante) is allowed to enter the contracted party’s premises for audits |
| Technical regulation | RTCR 505:2022 | 11.8.6 | Each product or analytical service covered by the contract is listed |
| Technical regulation | RTCR 505:2022 | 11.8.7 | Complete information of both parties, the contract’s validity period and the type of products covered |
| Technical regulation | RTCR 505:2022 | Article 16.3 | At renewal, where the contract is not in the dossier or has expired, a currently valid contract must be submitted |
| Technical regulation | RTCR 505:2022 | Articles 18.9.4 / 18.10.3 / 18.11.3 / 18.16.5 | The contract must be submitted in the relevant change scenarios |
3. Expert insights
Insight 1. Article 11.8 accepts a relevant extract of the contract (extracto relativo a las partes del contrato de fabricación), which is a pragmatic burden-reducing design. Many manufacturing contracts contain confidential commercial clauses on pricing and exclusivity, and submitting the full text is unrealistic. The regulation allows only the parts concerning the contracting parties to be submitted, provided the seven mandatory items are all contained in the extract. Companies should therefore compile a dedicated compliance extract that presents the seven items together, rather than simply copying the first pages of the contract.
Insight 2. Article 11.8.1 differentiates the signature form for domestic and foreign entities. The text provides that the contract is signed by the holder and the manufacturer jointly or separately, and that where the holder and/or the manufacturer is a Costa Rican entity, the document must be submitted with the digital signatures of the legal representatives of both parties. This means that where a domestic entity participates, the signature form escalates to a digital signature, connecting with the central bank standards referenced in Article 10.2. Signatures by foreign entities follow the legalisation or apostille route of Article 10.17.
Insight 3. Article 11.8.5 writes the audit right into the contract as a mandatory clause, and it is the core of the allocation of quality system responsibility. The provision requires the contract expressly to allow the contracting party (contratante) to enter the contracted party’s (contratista) premises to conduct audits. The meaning is that under the Costa Rican regulatory view, the holder cannot outsource quality responsibility entirely — the contract must preserve the holder’s on-site audit right. Without this clause, traceability of the quality system is surrendered at the contract level.
Insight 4. The contract’s validity period is a mandatory item under Article 11.8.7 and is linked to the renewal provisions. Article 11.8.7 requires the validity period to be stated; Article 16.3 provides that at renewal, if the contract in the dossier has expired, a currently valid contract must be submitted. This linkage means the expiry date should be monitored in the registration ledger, and the contract should be renewed before or in step with the renewal window; otherwise a documentation deficiency will arise at renewal.
4. Practical recommendations
- Compile a dedicated contract compliance extract organised around the seven-item list, avoiding submission of the full text containing trade secrets.
- Where a Costa Rican entity participates, use the legal representative’s digital signature (11.8.1); foreign entities process legalisation or apostille under Article 10.17.
- Write the contracting party’s on-site audit right expressly into the contract (11.8.5); do not omit it.
- State the validity period and the type of products covered (11.8.7), and monitor the expiry date in the registration ledger.
- Before renewal, check under Article 16.3 that the contract is still valid; where it has expired, renew it first and then file for renewal.
5. Verification checklist
- □ Contract or compliance extract submitted (11.8)
- □ Signed by both parties with the required digital signature (11.8.1)
- □ BPM compliance commitment included (11.8.2)
- □ Production and analytical conditions specified (11.8.3)
- □ Materials and non-conforming product handling described (11.8.4)
- □ Contracting party’s audit right included (11.8.5)
- □ Covered products or services listed (11.8.6)
- □ Parties’ information, validity period and product type stated (11.8.7)
Related reading: [BPM certificate and the deferral effect of Transitorio I](/costa-rica-medical-device-registration/bpm-certificate-and-transitorio-i-deferral/) | [Five-year validity and the eleven renewal items](/costa-rica-medical-device-registration/five-year-validity-and-renewal-eleven-items/) | [Nineteen categories of post-registration changes and four notification items](/costa-rica-medical-device-registration/post-registration-changes-nineteen-categories/)
Regulatory information verified as of October 29, 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Costa Rican market. Our team manages Ministry of Health (Ministerio de Salud) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us